Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Alcon Inc.
  6. Summary
    ALC   CH0432492467

ALCON INC.

(ALC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
64.16(c) 63.96(c) 65.66(c) 65.92(c) 66(c) Last
507 353 602 662 745 647 695 923 747 307 Volume
-1.93% -0.31% +2.66% +0.40% +0.12% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 7 926 M - -
Net income 2021 209 M - -
Net Debt 2021 2 477 M - -
P/E ratio 2021 128x
Yield 2021 0,15%
Sales 2022 8 449 M - -
Net income 2022 421 M - -
Net Debt 2022 1 870 M - -
P/E ratio 2022 71,9x
Yield 2022 0,25%
Capitalization 35 709 M 35 681 M -
EV / Sales 2021 4,82x
EV / Sales 2022 4,45x
Nbr of Employees 23 000
Free-Float 97,8%
More Financials
Company
Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal,... 
More about the company
Ratings of Alcon Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about ALCON INC.
07/22ALCON : Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Lar..
BU
07/01Dry Eye Syndrome Market 2026|Industry Analysis with Top Manufacturers- Allerg..
AQ
06/29GLOBAL MARKETS LIVE : United Airlines, Ford, Wells Fargo, Facebook, UBS...
06/29ALCON : Names Chief Information, Transformation Officer
MT
06/28ALCON : Announces Executive Committee Changes (Form 6-K)
PU
06/28Alcon Announces Executive Committee Changes, with Effect from September 01, 2..
CI
06/28ALCON : Announces Executive Committee Changes
BU
06/16ALCON : ORA System – the First and Only Database for Real-Time IOL Calcula..
PU
06/07ALCON : to Showcase Vision Care Innovation, Including Clinical Data for its Fort..
PU
06/07ALCON : to Showcase Vision Care Innovation, Including Clinical Data for its Fort..
BU
06/01ALCON : Retina Fellows Institute Brings Together World-Class Ophthalmology Leade..
PU
05/27ALCON : AlphaValue/Baader Europe Lowers Price Target on Alcon, Maintains Add Rec..
MT
05/20ALCON : Proud Partner of UK RCOphth National Ophthalmology Database; Data Highli..
PU
05/10ALCON : Day by Day Lowers Price Target on Alcon, Maintains Buy Recommendation
MT
05/06ALCON : Citigroup Lifts Alcon to Neutral From Sell, Price Target to $72 From $65
MT
More news
News in other languages on ALCON INC.
07/28Aktien Schweiz etwas fester zur Wochenmitte
07/22Alcon kündigt Vorlage von positiven Produktdaten an US-Fachkonferenz an
07/19Aktien Schweiz schließen schwach - Indexschwergewichte stabilisieren
06/29STOCK MARKET PARIS : Comme un air de déjà-vu
06/29EN DIRECT DES MARCHES  : Airbus, Rexel, GTT, AB Science, Wells Fargo, Ford, UBS,..
More news
Analyst Recommendations on ALCON INC.
More recommendations
Chart ALCON INC.
Duration : Period :
Alcon Inc. Technical Analysis Chart | ALC | CH0432492467 | MarketScreener
Technical analysis trends ALCON INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 72,89 $
Average target price 77,65 $
Spread / Average Target 6,53%
EPS Revisions
Managers and Directors
David J. Endicott Chief Executive Officer & Director
Timothy C. Stonesifer Chief Financial Officer & Senior Vice President
F. Michael Ball Chairman
Franck Leveiller Head-Global Research & Development
Sue-Jean Lin Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
ALCON INC.12.17%35 681
THE COOPER COMPANIES, INC.16.09%20 771
AUTEK CHINA INC.55.79%12 001
MENICON CO., LTD.27.84%2 752
PEGAVISION CORPORATION58.30%1 122
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.49.58%974